Choi DH - Search Results

1

Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients.

Noh JM, Choi DH, Nam SJ, Lee JE, Kim JW, Kim SW, Kang E, Lee MH, Ahn SH, Kim KS, Park SK, Haffty BG; Korea Breast Cancer Study Group. Noh JM, et al. Among authors: choi dh. Breast Cancer Res Treat. 2012 Jan;131(1):217-22. doi: 10.1007/s10549-011-1718-5. Epub 2011 Aug 17. Breast Cancer Res Treat. 2012. PMID: 21847643

2

Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.

Rodrigues N, Carter D, Dillon D, Parisot N, Choi DH, Haffty BG. Rodrigues N, et al. Among authors: choi dh. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1331-5. doi: 10.1016/s0360-3016(02)03747-1. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459354

3

A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma.

Choi DH, Shin DB, Lee MH, Lee DW, Dhandapani D, Carter D, King BL, Haffty BG. Choi DH, et al. Cancer. 2003 Oct 15;98(8):1587-95. doi: 10.1002/cncr.11703. Cancer. 2003. PMID: 14534873 Free article.

4

Molecular markers for prognosis after isolated postmastectomy chest wall recurrence.

Haffty BG, Hauser A, Choi DH, Parisot N, Rimm D, King B, Carter D. Haffty BG, et al. Among authors: choi dh. Cancer. 2004 Jan 15;100(2):252-63. doi: 10.1002/cncr.11915. Cancer. 2004. PMID: 14716758 Free article.

5

Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.

Choi DH, Lee MH, Bale AE, Carter D, Haffty BG. Choi DH, et al. J Clin Oncol. 2004 May 1;22(9):1638-45. doi: 10.1200/JCO.2004.04.179. J Clin Oncol. 2004. PMID: 15117986

6

Immunohistochemical biomarkers in patients with early-onset breast carcinoma by tissue microarray.

Choi DH, Kim S, Rimm DL, Carter D, Haffty BG. Choi DH, et al. Cancer J. 2005 Sep-Oct;11(5):404-11. doi: 10.1097/00130404-200509000-00008. Cancer J. 2005. PMID: 16259871

7

Double heterozygotes for non-Caucasian families with mutations in BRCA-1 and BRCA-2 genes.

Choi DH, Lee MH, Haffty BG. Choi DH, et al. Breast J. 2006 May-Jun;12(3):216-20. doi: 10.1111/j.1075-122X.2006.00245.x. Breast J. 2006. PMID: 16684319

8

The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation.

Choi DH, Cho DY, Lee MH, Park HS, Ahn SH, Son BH, Haffty BG. Choi DH, et al. Breast Cancer Res Treat. 2008 Dec;112(3):569-73. doi: 10.1007/s10549-007-9878-z. Epub 2008 Jan 3. Breast Cancer Res Treat. 2008. PMID: 18175216

9

A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or = 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?

Park YH, Kim ST, Cho EY, Choi YL, Ok ON, Baek HJ, Lee JE, Nam SJ, Yang JH, Park W, Choi DH, Huh SJ, Ahn JS, Im YH. Park YH, et al. Among authors: choi dh, choi yl. Breast Cancer Res Treat. 2010 Feb;119(3):653-61. doi: 10.1007/s10549-009-0665-x. Breast Cancer Res Treat. 2010. PMID: 19957028

10

PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations.

Kim JH, Choi DH, Cho DY, Ahn SH, Son BH, Haffty BG. Kim JH, et al. Among authors: choi dh. Breast Cancer Res Treat. 2010 Jul;122(1):303-6. doi: 10.1007/s10549-010-0806-2. Epub 2010 Mar 6. Breast Cancer Res Treat. 2010. PMID: 20213081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,199 results

Search Page

Filters